CompletedPhase 2NCT00324454

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Duke University
Principal Investigator
Richard S Bedlack, MD, PhD
Duke University
Intervention
Levetiracetam(biological)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
20062008

Study locations (1)

Collaborators

UCB Pharma

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00324454 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials